Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

Genome Therapeutics, Amgen Collaborate On Bone Diseases

Jan. 3, 2003

By Aaron Lorenzo

Genome Therapeutics, Amgen Collaborate On Bone Diseases

Jan. 3, 2003

By Aaron Lorenzo

Cellegy Enters Deal With PDL For Marketing Of Tostrex Gel

Jan. 3, 2003

By Aaron Lorenzo

ChemoCentryx Focuses Efforts On Targeting Chemokine System

Jan. 2, 2003

By Aaron Lorenzo

ChemoCentryx Focuses Efforts On Targeting Chemokine System

Jan. 2, 2003

By Aaron Lorenzo

Amphora Adds $23M In Series B To Carry Out Discovery Programs

Dec. 31, 2002

By Aaron Lorenzo

Amphora Adds $23M In Series B To Carry Out Discovery Programs

Dec. 31, 2002

By Aaron Lorenzo

BioRexis Completes Series A Round For Peptides, Antibodies

Dec. 30, 2002

By Aaron Lorenzo

BioRexis Completes Series A Round For Peptides, Antibodies

Dec. 30, 2002

By Aaron Lorenzo

Transave Raises $12M For Work Targeting Diseases Of The Lung

Dec. 27, 2002

By Aaron Lorenzo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...